Oxaliplatin-Induced Lung Injury with Allergic Reaction
A 79-year-old man was diagnosed as stage IV colon cancer and treated with a modified FOLFOX6 (mFOLFOX6) regimen.On the 12th cycle,we observed erythema and dyspnea.Radiographs showed ground grass opacities.Blood tests showed elevated levels of eosinophils and immunoglobulin E.We diagnosed this findin...
Saved in:
Published in: | Chinese journal of cancer research Vol. 23; no. 3; pp. 232 - 235 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Heidelberg
Chinese Anti-Cancer Association
01-09-2011
Springer-Verlag Berlin Heidelberg |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | A 79-year-old man was diagnosed as stage IV colon cancer and treated with a modified FOLFOX6 (mFOLFOX6) regimen.On the 12th cycle,we observed erythema and dyspnea.Radiographs showed ground grass opacities.Blood tests showed elevated levels of eosinophils and immunoglobulin E.We diagnosed this finding as response to drug allergy and administered high-dose methylprednisolone.The treatment was successful and he was discharged.The drug lymphocyte stimulating test against oxaliplatin was positive,indicating a type I and IV allergic reaction due to oxaliplatin.Regimens including oxaliplatin must be carefully monitored and frequent blood tests and chest radiographs are needed. |
---|---|
AbstractList | A 79-year-old man was diagnosed as stage IV colon cancer and treated with a modified FOLFOX6 (mFOLFOX6) regimen. On the 12th cycle, we observed erythema and dyspnea. Radiographs showed ground grass opacities. Blood tests showed elevated levels of eosinophils and immunoglobulin E. We diagnosed this finding as response to drug allergy and administered high-dose methylprednisolone. The treatment was successful and he was discharged. The drug lymphocyte stimulating test against oxaliplatin was positive, indicating a type I and IV allergic reaction due to oxaliplatin. Regimens including oxaliplatin must be carefully monitored and frequent blood tests and chest radiographs are needed. A 79-year-old man was diagnosed as stage IV colon cancer and treated with a modified FOLFOX6 (mFOLFOX6) regimen.On the 12th cycle,we observed erythema and dyspnea.Radiographs showed ground grass opacities.Blood tests showed elevated levels of eosinophils and immunoglobulin E.We diagnosed this finding as response to drug allergy and administered high-dose methylprednisolone.The treatment was successful and he was discharged.The drug lymphocyte stimulating test against oxaliplatin was positive,indicating a type I and IV allergic reaction due to oxaliplatin.Regimens including oxaliplatin must be carefully monitored and frequent blood tests and chest radiographs are needed. |
Author | Tetsuya Homma Masatsugu Kuro.kawa Yoshitaka Yamamoto Satoshi Matsukura Koushi leki Shintaro Suzuki Miho Oclaka Shin Watanabe Munehiro Yamaguchi Mitsuru Adachi |
AuthorAffiliation | Division of AIlergology and Respiratory Medicine, Division of Internal Medicine, School of Medicine, Showa University,1-5-8 Hatanodai, 5hinagawa-ku, Tokyo, Japan |
Author_xml | – sequence: 1 givenname: Tetsuya surname: Homma fullname: Homma, Tetsuya email: oldham726@yahoo.co.jp organization: Division of Allergology and Respiratory Medicine, Division of Internal Medicine, School of Medicine, Showa University – sequence: 2 givenname: Masatsugu surname: Kurokawa fullname: Kurokawa, Masatsugu organization: Division of Allergology and Respiratory Medicine, Division of Internal Medicine, School of Medicine, Showa University – sequence: 3 givenname: Yoshitaka surname: Yamamoto fullname: Yamamoto, Yoshitaka organization: Division of Allergology and Respiratory Medicine, Division of Internal Medicine, School of Medicine, Showa University – sequence: 4 givenname: Satoshi surname: Matsukura fullname: Matsukura, Satoshi organization: Division of Allergology and Respiratory Medicine, Division of Internal Medicine, School of Medicine, Showa University – sequence: 5 givenname: Koushi surname: Ieki fullname: Ieki, Koushi organization: Division of Allergology and Respiratory Medicine, Division of Internal Medicine, School of Medicine, Showa University – sequence: 6 givenname: Shintaro surname: Suzuki fullname: Suzuki, Shintaro organization: Division of Allergology and Respiratory Medicine, Division of Internal Medicine, School of Medicine, Showa University – sequence: 7 givenname: Miho surname: Odaka fullname: Odaka, Miho organization: Division of Allergology and Respiratory Medicine, Division of Internal Medicine, School of Medicine, Showa University – sequence: 8 givenname: Shin surname: Watanabe fullname: Watanabe, Shin organization: Division of Allergology and Respiratory Medicine, Division of Internal Medicine, School of Medicine, Showa University – sequence: 9 givenname: Munehiro surname: Yamaguchi fullname: Yamaguchi, Munehiro organization: Division of Allergology and Respiratory Medicine, Division of Internal Medicine, School of Medicine, Showa University – sequence: 10 givenname: Mitsuru surname: Adachi fullname: Adachi, Mitsuru organization: Division of Allergology and Respiratory Medicine, Division of Internal Medicine, School of Medicine, Showa University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23467619$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kdtKAzEQhoMo1tMDeCPrA0Rnkk3S3AgiHgoFQfQ6pNnsdss2W7O7at_eSLXojVczMPN_E74ckt3QBk_IKcIFAqjLDlEqoIBIgXFG1zvkALXmFCTH3dQDANUS8hE57LoFgFACcJ-MGM-lkqgPiHz8sE29amxfBzoJxeB8kU2HUGWTsBjiOnuv-3l23TQ-VrXLnrx1fd2GY7JX2qbzJ9_1iLzc3T7fPNDp4_3k5npKXc5FT7XVTnEmnSshx5nmUs_GJQcNKJhAXsxwXCip8pxZhcqWOi-1YqlyzoQU_IhcbbirYbb0hfOhj7Yxq1gvbVyb1tbm7yTUc1O1b4aLsRISEwA3ABfbrou-3GYRzJdEs5FokkTzJdGsU-bs99Ft4sdaWmCbhS6NQuWjWbRDDEnEv9Tz75fM21C9ptwWnKefASYY_wTuZ4nD |
CitedBy_id | crossref_primary_10_1186_s12885_017_3576_y crossref_primary_10_1159_000368185 |
Cites_doi | 10.1200/JCO.2006.09.6305 10.1056/NEJMoa032709 10.1007/BF02717006 10.1016/j.rmed.2007.09.001 10.1378/chest.07-0536 10.3816/CCC.2010.n.024 10.2174/092986707779313345 10.1007/s12094-009-0364-4 10.1007/s10147-008-0863-2 10.1007/s12094-006-0072-2 10.1093/annonc/mdh095 10.1097/00000421-200208000-00014 10.1159/000127425 10.1093/annonc/mdq061 10.1159/000107467 10.1056/NEJMoa071834 10.1007/s12094-008-0285-7 10.1038/clpt.1981.154 10.1038/sj.bjc.6602064 10.1111/j.1743-7563.2008.00187.x 10.1200/JCO.2002.20.4.1146 10.3748/wjg.v12.i36.5907 10.1155/2010/207084 10.1183/09031936.93.05070791 10.1183/09031936.01.18010243 |
ContentType | Journal Article |
Copyright | Chinese Anti-Cancer Association and Springer-Verlag Berlin Heidelberg 2011 2011 Chinese Anti-Cancer Association and Springer-Verlag Berlin Heidelberg 2011 2011 Chinese Anti-Cancer Association and Springer-Verlag Berlin Heidelberg |
Copyright_xml | – notice: Chinese Anti-Cancer Association and Springer-Verlag Berlin Heidelberg 2011 – notice: 2011 Chinese Anti-Cancer Association and Springer-Verlag Berlin Heidelberg 2011 2011 Chinese Anti-Cancer Association and Springer-Verlag Berlin Heidelberg |
DBID | 2RA 92L CQIGP W91 ~WA NPM AAYXX CITATION 5PM |
DOI | 10.1007/s11670-011-0232-y |
DatabaseName | 维普_期刊 中文科技期刊数据库-CALIS站点 维普中文期刊数据库 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 PubMed CrossRef PubMed Central (Full Participant titles) |
DatabaseTitle | PubMed CrossRef |
DatabaseTitleList | PubMed |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Oxaliplatin-Induced Lung Injury with Allergic Reaction |
EISSN | 1993-0631 |
EndPage | 235 |
ExternalDocumentID | 10_1007_s11670_011_0232_y 23467619 40050252 |
Genre | Case Reports |
GroupedDBID | --- -05 -0E -5E -5G -BR -SE -S~ -Y2 .86 0R~ 0VY 1N0 2.D 29B 2B. 2C~ 2JY 2RA 2VQ 2~H 30V 4.4 408 40D 5GY 5VR 5VS 5XA 5XF 5XL 6NX 8TC 8UJ 92F 92I 92L 92M 93N 93R 95. 95~ 9D9 9DE AAIAL AANXM AARHV ABJNI ABKZE ABTEG ACGFS ACOMO ADINQ ADKPE ADQRH ADRFC AENEX AFLOW AFNRJ AFUIB AFWTZ AGGDS AGJBK AHBYD AHKAY AHSBF ALMA_UNASSIGNED_HOLDINGS AMKLP ASPBG AVWKF AZFZN BA0 BBWZM BGNMA CAG CAJEE CAJUS CCEZO CHBEP CIEJG COF CQIGP CS3 CSCUP CW9 DIK DU5 EBS EJD FA0 FEDTE GQ6 GX1 HF~ HG6 HMJXF HVGLF HYE HZ~ I~X M4Y MA- N2Q NDZJH NF0 NU0 O9- O93 O9G O9I OK1 OVD P19 P9S PT5 Q-- Q-4 QOK QOS R-E R89 R9I RNI ROL RPM RPX RSV RT5 RZK S1Z S26 S27 S28 S37 S3B SCL SDE SDH SMD SOJ SZN T13 T16 T8U TCJ TEORI TGQ TT1 TUC U1F U1G U2A U5E U5O VC2 W91 WFFXF WK8 ~A9 ~N8 ~WA AAPBV AAXDM AAYZH AFBBN NPM AAYXX CITATION 5PM |
ID | FETCH-LOGICAL-c435t-9a9c7326ccf041b9369b8f3090152513db18d767442a717af94f972af93325653 |
IEDL.DBID | RPM |
ISSN | 1000-9604 |
IngestDate | Tue Sep 17 21:02:26 EDT 2024 Thu Nov 21 21:11:22 EST 2024 Wed Oct 16 00:50:16 EDT 2024 Sat Dec 16 12:02:50 EST 2023 Wed Feb 14 10:48:17 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Immunoglobulin E Oxaliplatin Drug-induced pneumonia mFOLFOX6 Drug lymphocyte stimulating test |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c435t-9a9c7326ccf041b9369b8f3090152513db18d767442a717af94f972af93325653 |
Notes | A 79-year-old man was diagnosed as stage IV colon cancer and treated with a modified FOLFOX6 (mFOLFOX6) regimen.On the 12th cycle,we observed erythema and dyspnea.Radiographs showed ground grass opacities.Blood tests showed elevated levels of eosinophils and immunoglobulin E.We diagnosed this finding as response to drug allergy and administered high-dose methylprednisolone.The treatment was successful and he was discharged.The drug lymphocyte stimulating test against oxaliplatin was positive,indicating a type I and IV allergic reaction due to oxaliplatin.Regimens including oxaliplatin must be carefully monitored and frequent blood tests and chest radiographs are needed. 11-2591/R Oxaliplatin; mFOLFOX6; Drug-induced pneumonia; Drug lymphocyte stimulating test; Immunoglobulin E Tetsuya Homma,Masatsugu Kurokawa,Yoshitaka Yamamoto,Satoshi Matsukura,Koushi Ieki,Shintaro Suzuki,Miho Odaka,Shin Watanabe,Munehiro Yamaguchi,Mitsuru Adachi (Division of Allergology and Respiratory Medicine,Division of Internal Medicine,School of Medicine,Showa University,1-5-8 Hatanodai,Shinagawa-ku,Tokyo,Japan) E-mail: oldham726@yahoo.co.jp Corresponding author. |
OpenAccessLink | https://europepmc.org/articles/pmc3587561?pdf=render |
PMID | 23467619 |
PageCount | 4 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3587561 crossref_primary_10_1007_s11670_011_0232_y pubmed_primary_23467619 springer_journals_10_1007_s11670_011_0232_y chongqing_primary_40050252 |
PublicationCentury | 2000 |
PublicationDate | 2011-09-01 |
PublicationDateYYYYMMDD | 2011-09-01 |
PublicationDate_xml | – month: 09 year: 2011 text: 2011-09-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Heidelberg |
PublicationPlace_xml | – name: Heidelberg – name: China |
PublicationTitle | Chinese journal of cancer research |
PublicationTitleAbbrev | Chin. J. Cancer Res |
PublicationTitleAlternate | Chinese Journal of Cancer Research |
PublicationYear | 2011 |
Publisher | Chinese Anti-Cancer Association Springer-Verlag Berlin Heidelberg |
Publisher_xml | – name: Chinese Anti-Cancer Association – name: Springer-Verlag Berlin Heidelberg |
References | Costabel, Teschler, Guzman (CR4) 1992; 5 Pena Alvarez, Suh Oh, Sáenz de Miera Rodríguez (CR20) 2009; 11 Arévalo Lobera, Sagastibeltza Mariñelarena, Elejoste Echeberría (CR18) 2008; 10 Pagani, Bonadonna, Senna (CR25) 2008; 145 Trisolini, Lazzari Agli, Tassinari (CR9) 2001; 18 Piccolo, Feeney, Tribe (CR19) 2008; 4 Muneoka, Shirai, Sasaki (CR21) 2009; 14 Jung, Kil, Choi (CR13) 2006; 10 Ohori, Takahashi, Ogasawara (CR24) 2009; 36 Yagüe, Soy, Merino (CR11) 2005; 7 Garrido, O’Brien, González (CR16) 2007; 132 Rowinsky, Eisenhauer, Chaudhry (CR28) 1993; 20 Kinnula, Vuorinen, Ilumets (CR6) 2007; 14 CR3 Wilcox, Ryu, Kalra (CR17) 2008; 102 Fekrazad, Eberhardt, Jones (CR22) 2010; 9 Shimura, Fuse, Yoshino (CR23) 2010; 21 Mundt, Mochmann, Ebhardt (CR15) 2007; 73 Rubbia-Brandt, Audard, Sartoretti (CR5) 2004; 15 Naranjo, Busto, Sellers (CR8) 1981; 30 André, Boni, Mounedji-Boudiaf (CR1) 2004; 350 Giantonio, Catalano, Meropol (CR27) 2007; 25 Pasetto, Monfardini (CR14) 2006; 12 Jonker, O’Callaghan, Karapetis (CR26) 2007; 357 Müller, White, Jiang (CR7) 2004; 91 Gagnadoux, Roiron, Carrie (CR10) 2002; 25 Meyer, Zuberbier, Worm (CR2) 2002; 20 Ruiz-Casado, García, Racionero (CR12) 2006; 8 L.M. Pasetto (232_CR14) 2006; 12 D.J. Jonker (232_CR26) 2007; 357 A. Ruiz-Casado (232_CR12) 2006; 8 M. Garrido (232_CR16) 2007; 132 K. Muneoka (232_CR21) 2009; 14 U. Costabel (232_CR4) 1992; 5 V.L. Kinnula (232_CR6) 2007; 14 S. Arévalo Lobera (232_CR18) 2008; 10 T. Shimura (232_CR23) 2010; 21 R. Trisolini (232_CR9) 2001; 18 F. Gagnadoux (232_CR10) 2002; 25 M.H. Fekrazad (232_CR22) 2010; 9 K.H. Jung (232_CR13) 2006; 10 232_CR3 L. Rubbia-Brandt (232_CR5) 2004; 15 F. Piccolo (232_CR19) 2008; 4 C. Pena Alvarez (232_CR20) 2009; 11 C.A. Naranjo (232_CR8) 1981; 30 P. Mundt (232_CR15) 2007; 73 B.J. Giantonio (232_CR27) 2007; 25 E.K. Rowinsky (232_CR28) 1993; 20 T. André (232_CR1) 2004; 350 B.E. Wilcox (232_CR17) 2008; 102 L. Meyer (232_CR2) 2002; 20 N.L. Müller (232_CR7) 2004; 91 M. Pagani (232_CR25) 2008; 145 X.H. Yagüe (232_CR11) 2005; 7 H. Ohori (232_CR24) 2009; 36 |
References_xml | – volume: 18 start-page: 243 year: 2001 end-page: 245 ident: CR9 article-title: Acute lung injury associated with 5-fluorouracil and oxaliplatinum combined chemotherapy publication-title: Eur Respir J contributor: fullname: Tassinari – volume: 12 start-page: 5907 year: 2006 end-page: 5908 ident: CR14 article-title: Is acute dyspnea related to oxaliplatin administration? publication-title: World J Gastroenterol contributor: fullname: Monfardini – volume: 25 start-page: 1539 year: 2007 end-page: 1544 ident: CR27 article-title: Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200 publication-title: J Clin Oncol doi: 10.1200/JCO.2006.09.6305 contributor: fullname: Meropol – volume: 350 start-page: 2343 year: 2004 end-page: 2351 ident: CR1 article-title: Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa032709 contributor: fullname: Mounedji-Boudiaf – volume: 20 start-page: 1 issue: 4Suppl3 year: 1993 end-page: 15 ident: CR28 article-title: Clinical toxicities encountered with paclitaxel (Taxol) publication-title: Semin Oncol contributor: fullname: Chaudhry – volume: 7 start-page: 515 year: 2005 end-page: 517 ident: CR11 article-title: Interstitial pneumonitis after oxaliplatin treatment in colorectal cancer publication-title: Clin Transl Oncol doi: 10.1007/BF02717006 contributor: fullname: Merino – volume: 102 start-page: 273 year: 2008 end-page: 279 ident: CR17 article-title: Exacerbation of pre-existing interstitial lung disease after oxaliplatin therapy: a report of three cases publication-title: Respir Med doi: 10.1016/j.rmed.2007.09.001 contributor: fullname: Kalra – volume: 10 start-page: 1181 year: 2006 end-page: 1182 ident: CR13 article-title: Interstitial lung diseases in patients treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) publication-title: Int J Tuberc Lung Dis contributor: fullname: Choi – volume: 132 start-page: 1997 year: 2007 end-page: 1999 ident: CR16 article-title: Cryptogenic organizing pneumonitis during oxaliplatin chemotherapy for colorectal cancer: case report publication-title: Chest doi: 10.1378/chest.07-0536 contributor: fullname: González – volume: 9 start-page: 177 year: 2010 end-page: 178 ident: CR22 article-title: Development of bronchiolitis obliterans organizing pneumonia with platinum-based chemotherapy for metastatic rectal cancer publication-title: Clin Colorectal Cancer doi: 10.3816/CCC.2010.n.024 contributor: fullname: Jones – volume: 5 start-page: 791 year: 1992 end-page: 797 ident: CR4 article-title: Bronchiolitis obliterans organizing pneumonia (BOOP): the cytological and immunocytological profile of bronchoalveolar lavage publication-title: Eur Respir J contributor: fullname: Guzman – volume: 14 start-page: 213 year: 2007 end-page: 222 ident: CR6 article-title: Thiol proteins, redox modulation and parenchymal lung disease publication-title: Curr Med Chem doi: 10.2174/092986707779313345 contributor: fullname: Ilumets – volume: 36 start-page: 295 year: 2009 end-page: 298 ident: CR24 article-title: Two cases of interstitial lung diseases in patients treated with oxaliplatin, 5-fluorouracil and Leucovorin (FOLFOX) publication-title: Gan To Kagaku Ryoho contributor: fullname: Ogasawara – volume: 11 start-page: 332 year: 2009 end-page: 333 ident: CR20 article-title: Interstitial lung disease associated with oxaliplatin: description of two cases publication-title: Clin Transl Oncol doi: 10.1007/s12094-009-0364-4 contributor: fullname: Sáenz de Miera Rodríguez – volume: 14 start-page: 457 year: 2009 end-page: 459 ident: CR21 article-title: Interstitial pneumonia arising in a patient treated with oxaliplatin, 5-fluorouracil, and, leucovorin (FOLFOX) publication-title: Int J Clin Oncol doi: 10.1007/s10147-008-0863-2 contributor: fullname: Sasaki – volume: 8 start-page: 624 year: 2006 ident: CR12 article-title: Pulmonary toxicity of 5-fluoracil and oxaliplatin publication-title: Clin Transl Oncol doi: 10.1007/s12094-006-0072-2 contributor: fullname: Racionero – volume: 15 start-page: 460 year: 2004 end-page: 466 ident: CR5 article-title: Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer publication-title: Ann Oncol doi: 10.1093/annonc/mdh095 contributor: fullname: Sartoretti – volume: 25 start-page: 388 year: 2002 end-page: 390 ident: CR10 article-title: Eosinophilic lung disease under chemotherapy with oxaliplatin for colorectal cancer publication-title: Am J Clin Oncol doi: 10.1097/00000421-200208000-00014 contributor: fullname: Carrie – volume: 20 start-page: 1146 year: 2002 end-page: 1147 ident: CR2 article-title: Hypersensitivity reactions to oxaliplatin: cross-reactivity to carboplatin and the introduction of a desensitization schedule publication-title: J Clin Oncol contributor: fullname: Worm – volume: 73 start-page: 270 year: 2007 end-page: 272 ident: CR15 article-title: Pulmonary fibrosis after chemotherapy with oxaliplatin and 5-fluorouracil for colorectal cancer publication-title: Oncology doi: 10.1159/000127425 contributor: fullname: Ebhardt – volume: 21 start-page: 2005 year: 2010 end-page: 2010 ident: CR23 article-title: Clinical features of interstitial lung disease induced by standard chemotherapy (FOLFOX or FOLFIRI) for colorectal cancer publication-title: Ann Oncol doi: 10.1093/annonc/mdq061 contributor: fullname: Yoshino – volume: 145 start-page: 54 year: 2008 end-page: 57 ident: CR25 article-title: Standardization of skin tests for diagnosis and prevention of hypersensitivity reactions to oxaliplatin publication-title: Int Arch Allergy Immuno doi: 10.1159/000107467 contributor: fullname: Senna – ident: CR3 – volume: 357 start-page: 2040 year: 2007 end-page: 2048 ident: CR26 article-title: Cetuximab for the treatment of colorectal cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa071834 contributor: fullname: Karapetis – volume: 10 start-page: 764 year: 2008 end-page: 767 ident: CR18 article-title: Fatal pneumonitis induced by oxaliplatin publication-title: Clin Transl Oncol doi: 10.1007/s12094-008-0285-7 contributor: fullname: Elejoste Echeberría – volume: 30 start-page: 239 year: 1981 end-page: 245 ident: CR8 article-title: A method for estimating the probability of adverse drug reactions publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.1981.154 contributor: fullname: Sellers – volume: 91 start-page: S24 issue: 4Suppl3 year: 2004 end-page: S30 ident: CR7 article-title: Diagnosis and management of drug-associated interstitial lung disease publication-title: Br J Cancer doi: 10.1038/sj.bjc.6602064 contributor: fullname: Jiang – volume: 4 start-page: 175 year: 2008 end-page: 180 ident: CR19 article-title: Oxaliplatin-induced interstitial lung disease publication-title: Asian Pacific J Clin Oncol doi: 10.1111/j.1743-7563.2008.00187.x contributor: fullname: Tribe – volume: 21 start-page: 2005 year: 2010 ident: 232_CR23 publication-title: Ann Oncol doi: 10.1093/annonc/mdq061 contributor: fullname: T. Shimura – volume: 20 start-page: 1146 year: 2002 ident: 232_CR2 publication-title: J Clin Oncol doi: 10.1200/JCO.2002.20.4.1146 contributor: fullname: L. Meyer – volume: 8 start-page: 624 year: 2006 ident: 232_CR12 publication-title: Clin Transl Oncol doi: 10.1007/s12094-006-0072-2 contributor: fullname: A. Ruiz-Casado – volume: 7 start-page: 515 year: 2005 ident: 232_CR11 publication-title: Clin Transl Oncol doi: 10.1007/BF02717006 contributor: fullname: X.H. Yagüe – volume: 30 start-page: 239 year: 1981 ident: 232_CR8 publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.1981.154 contributor: fullname: C.A. Naranjo – volume: 15 start-page: 460 year: 2004 ident: 232_CR5 publication-title: Ann Oncol doi: 10.1093/annonc/mdh095 contributor: fullname: L. Rubbia-Brandt – volume: 10 start-page: 1181 year: 2006 ident: 232_CR13 publication-title: Int J Tuberc Lung Dis contributor: fullname: K.H. Jung – volume: 14 start-page: 457 year: 2009 ident: 232_CR21 publication-title: Int J Clin Oncol doi: 10.1007/s10147-008-0863-2 contributor: fullname: K. Muneoka – volume: 12 start-page: 5907 year: 2006 ident: 232_CR14 publication-title: World J Gastroenterol doi: 10.3748/wjg.v12.i36.5907 contributor: fullname: L.M. Pasetto – volume: 10 start-page: 764 year: 2008 ident: 232_CR18 publication-title: Clin Transl Oncol doi: 10.1007/s12094-008-0285-7 contributor: fullname: S. Arévalo Lobera – volume: 4 start-page: 175 year: 2008 ident: 232_CR19 publication-title: Asian Pacific J Clin Oncol doi: 10.1111/j.1743-7563.2008.00187.x contributor: fullname: F. Piccolo – volume: 91 start-page: S24 issue: 4Suppl3 year: 2004 ident: 232_CR7 publication-title: Br J Cancer doi: 10.1038/sj.bjc.6602064 contributor: fullname: N.L. Müller – volume: 36 start-page: 295 year: 2009 ident: 232_CR24 publication-title: Gan To Kagaku Ryoho contributor: fullname: H. Ohori – volume: 73 start-page: 270 year: 2007 ident: 232_CR15 publication-title: Oncology doi: 10.1159/000127425 contributor: fullname: P. Mundt – ident: 232_CR3 doi: 10.1155/2010/207084 – volume: 5 start-page: 791 year: 1992 ident: 232_CR4 publication-title: Eur Respir J doi: 10.1183/09031936.93.05070791 contributor: fullname: U. Costabel – volume: 25 start-page: 388 year: 2002 ident: 232_CR10 publication-title: Am J Clin Oncol doi: 10.1097/00000421-200208000-00014 contributor: fullname: F. Gagnadoux – volume: 25 start-page: 1539 year: 2007 ident: 232_CR27 publication-title: J Clin Oncol doi: 10.1200/JCO.2006.09.6305 contributor: fullname: B.J. Giantonio – volume: 9 start-page: 177 year: 2010 ident: 232_CR22 publication-title: Clin Colorectal Cancer doi: 10.3816/CCC.2010.n.024 contributor: fullname: M.H. Fekrazad – volume: 20 start-page: 1 issue: 4Suppl3 year: 1993 ident: 232_CR28 publication-title: Semin Oncol contributor: fullname: E.K. Rowinsky – volume: 102 start-page: 273 year: 2008 ident: 232_CR17 publication-title: Respir Med doi: 10.1016/j.rmed.2007.09.001 contributor: fullname: B.E. Wilcox – volume: 14 start-page: 213 year: 2007 ident: 232_CR6 publication-title: Curr Med Chem doi: 10.2174/092986707779313345 contributor: fullname: V.L. Kinnula – volume: 132 start-page: 1997 year: 2007 ident: 232_CR16 publication-title: Chest doi: 10.1378/chest.07-0536 contributor: fullname: M. Garrido – volume: 18 start-page: 243 year: 2001 ident: 232_CR9 publication-title: Eur Respir J doi: 10.1183/09031936.01.18010243 contributor: fullname: R. Trisolini – volume: 357 start-page: 2040 year: 2007 ident: 232_CR26 publication-title: N Engl J Med doi: 10.1056/NEJMoa071834 contributor: fullname: D.J. Jonker – volume: 11 start-page: 332 year: 2009 ident: 232_CR20 publication-title: Clin Transl Oncol doi: 10.1007/s12094-009-0364-4 contributor: fullname: C. Pena Alvarez – volume: 145 start-page: 54 year: 2008 ident: 232_CR25 publication-title: Int Arch Allergy Immuno doi: 10.1159/000107467 contributor: fullname: M. Pagani – volume: 350 start-page: 2343 year: 2004 ident: 232_CR1 publication-title: N Engl J Med doi: 10.1056/NEJMoa032709 contributor: fullname: T. André |
SSID | ssj0057501 |
Score | 1.9026939 |
Snippet | A 79-year-old man was diagnosed as stage IV colon cancer and treated with a modified FOLFOX6 (mFOLFOX6) regimen.On the 12th cycle,we observed erythema and... A 79-year-old man was diagnosed as stage IV colon cancer and treated with a modified FOLFOX6 (mFOLFOX6) regimen. On the 12th cycle, we observed erythema and... |
SourceID | pubmedcentral crossref pubmed springer chongqing |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 232 |
SubjectTerms | Case Report Medicine Medicine & Public Health 免疫球蛋白E 嗜酸性粒细胞 奥沙利铂 治疗方案 甲基强的松龙 肺损伤 诱导 过敏性反应 |
Title | Oxaliplatin-Induced Lung Injury with Allergic Reaction |
URI | http://lib.cqvip.com/qk/85190X/201103/40050252.html https://link.springer.com/article/10.1007/s11670-011-0232-y https://www.ncbi.nlm.nih.gov/pubmed/23467619 https://pubmed.ncbi.nlm.nih.gov/PMC3587561 |
Volume | 23 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwED7RLrAgEK8UqDIwgdwmcZ5jVVq14ikeElvkODYU0VBoK9F_z13SBBWJBWXIYEuxvth3n-277wBOuKMVV47HZGhp5mrBWRQqznSqI48nrkgU5Q4P7oPrp_C8RzI5XpkLkwfty2TUyt7GrWz0ksdWTsayXcaJtW-vutxDlu3b7RrUkBuWW_TC_CL9yGse07k1I-WR8iozz5ezfaqzQqeCyCTYgqSAOZoKn4R21tHeZM8f6DFWfFTlmH4HTf66Oc0dUn8LNpdM0uwUI96GNZXtgH_zhcR6QgFuGaOyHFKl5iUuaHOYvSJ8Jp27mh3K_0OTZ96pIq9hFx77vYfugC1LIzCJ_GbGIhHJAJmXlNpy7YSq8iWh5hZ5d2QsPE3sMCWdHtcRuGETOnJ1FDj45hxJjsf3oJ69Z-oATKEiO1GedgJLuLjZEEjJNNIGkVoSH8uARgVMPCkkMGKXdGMczzHgtESqavsRQia0Y0Q7JrTjhQH7BYRV1xJ8A4IVcKsOJH692oJzIhfBXs4BA87K3xAvV9_07xE0_v2dQ9goTpMpuuwI6rPPuTqG2jSdN5GIDy-a-ST8BuPk3D0 |
link.rule.ids | 230,315,729,782,786,887,27934,27935,53802,53804 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT4NAEJ5oPdSLj_jCJwdPmm2BhQJHo23a2FajNfFGlmXXRxSrton9985AwbSJl4YDh90EmGFnvp2d-QbglDtaceV4TAaWZq4WnIWB4kwnOvR47IpYUe1w-97vPwZXTaLJ8YpamCxpX8YvtfTtvZa-PGe5lcN3WS_yxOq3vUvuIcpu2PVlWMH1ajnFJj03wAhAsq7HFLlmxD1SHGZmFXN2gzqtUFwQsQSbEBkwR2PRIKqdKlqc9OkTfcaMlypd03za5NzZaeaSWusLfswGrE0xqHmRD2_Ckkq3oHHzg5B8SKlxKaOGHlIlZhdNgdlJX1HwJkVszQuqHERjad6pvCJiGx5azcFlm02bKjCJyGjEQhFKHzGblNpy7Zj6-cWB5hbhAsQ6PIntICGGH9cRuNUTOnR16Dt45xzhkcd3oJJ-pGoPTKFCO1aednxLuLhNEQjmNAIOkVgSL8uA_VKg0TAnz4hcYpxxPMeAs0LC5dgfhTJpKUItRaSlaGLAbi76cmqhNAP8GaWUE4g2e3YEFZDRZ08FbsB5ob5oum6__3-D_YWfcwLV9qDXjbqd_vUBrOYxacpRO4TK6GusjmD5OxkfZ7_wL21l8NE |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT8MwDLZ4SMCFh3h1vHrgBAprmz6PE2wCMQbiIXGr0jSBISiDbRL799jtWrRJXEA99JBIbe3G_uLYnwEOuaMVV47HZGhp5mrBWRQqznSqI48nrkgU1Q6f3wWdx_CsSTQ5VauvPGlfJt2T7PXtJOs-57mVvTdZL_PE6jdXp9xDlO3b9V6q67Mwj2vWcsuNemGEEYTknY8pes2If6Q80Myr5myfuq1QbBDxBBsRITBHg-ET3c4iWp3s6QP9xoSnqtzTdOrk1Plp7pZaK__4oFVYHmNRs1FMWYMZla2Df_2F0LxHKXIZo8YeUqVmG02CeZG9oAJMityaDaogRKNp3qqiMmIDHlrN-9NzNm6uwCQipAGLRCQDxG5Sasu1E-rrl4SaW4QPEPPwNLHDlJh-XEfglk_oyNVR4OCdc4RJHt-Euew9U9tgChXZifK0E1jCxe2KQFCnEXiI1JJ4WQbUKqHGvYJEI3aJecbxHAOOSilXYz9UyqSpGDUVk6bikQFbhfirqaXiDAgmFFNNIPrsyRFUQk6jPRa6AcelCuPx-u3__ga1Pz_nABZuzlpx-6JzuQNLRWiaUtV2YW7wOVR7MNtPh_v5X_wNNnbzUQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Oxaliplatin-induced+lung+injury+with+allergic+reaction&rft.jtitle=Chinese+journal+of+cancer+research&rft.au=Homma%2C+Tetsuya&rft.au=Kurokawa%2C+Masatsugu&rft.au=Yamamoto%2C+Yoshitaka&rft.au=Matsukura%2C+Satoshi&rft.date=2011-09-01&rft.pub=Chinese+Anti-Cancer+Association&rft.issn=1000-9604&rft.eissn=1993-0631&rft.volume=23&rft.issue=3&rft_id=info:doi/10.1007%2Fs11670-011-0232-y&rft.externalDocID=10_1007_s11670_011_0232_y |
thumbnail_s | http://sdu.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F85190X%2F85190X.jpg |